ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Fate and Function of CD8+ T Cells Primed by Fetal Antigen During Pregnancy.

P. Porrett,1 R. Xu,1 E. Wherry.2

1Surgery, University of Pennyslvania, Philadelphia, PA
2Microbiology, University of Pennsylvania, Philadelphia, PA

Meeting: 2017 American Transplant Congress

Abstract number: B32

Keywords: Pregnancy, T cells

Session Information

Session Name: Poster Session B: Allorecognition and T Cell Biology

Session Type: Poster Session

Date: Sunday, April 30, 2017

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

Background The long-term fate of maternal T cells primed by fetal antigen during pregnancy has not been well studied but may have significant impact for female transplant recipients. Although it has been predicted that these cells adopt a memory fate, recent data suggest that immunoregulatory mechanisms which dominate during pregnancy may alter fate decisions. We asked whether fetal antigen promoted the differentiation of canonical allospecific memory CD8+ T cells that pose a threat to an allograft. Methods Ova-specific OT-1 CD45.2+ congenic CD8+ T cells were adoptively transferred into Act-mOVA-mated pregnant CD45.1 B6 mice. CD8+ OT-1 T cell phenotype and cytokine production were analyzed 30 days after pup delivery. In additional experiments, congenic OT-1 T cells were sorted from parous mice and adoptively transferred into RAGKO recipients that subsequently received an Ova skin graft. Results Ova fetal antigen primed Ova-specific OT-1 T cells to divide and produce IFNgamma during pregnancy. These CD44+ antigen-experienced cells persisted in the repertoire of parous animals and expressed elevated levels of PD-1. When stimulated ex vivo with Ova peptide, these cells made substantially less IFNgamma than memory control animals that had been sensitized with a prior Ova skin graft (35% vs. 75%; p<.01). However, 100% of T cell deficient RAGKO mice that were transferred OT-1 T cells from parous mice rapidly rejected Ova skin grafts (Mean survival time: 8 days). Conclusion Antigen-experienced, PD-1 expressing CD8+ T cells primed during pregnancy persist in the repertoire of parous animals. Despite limited cytokine producing capacity and an altered phenotype compared to canonical memory T cells, these cells maintain adequate cytotoxicity to pose a threat to an organ transplant.

CITATION INFORMATION: Porrett P, Xu R, Wherry E. Fate and Function of CD8+ T Cells Primed by Fetal Antigen During Pregnancy. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Porrett P, Xu R, Wherry E. Fate and Function of CD8+ T Cells Primed by Fetal Antigen During Pregnancy. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/fate-and-function-of-cd8-t-cells-primed-by-fetal-antigen-during-pregnancy/. Accessed May 12, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences